OpenLegislation

Article 2 DefinitionsF1

United Kingdom

Original text. Later amendments are not shown.

For the purposes of this Regulation:

  1. (a)

    ‘medicinal product’ means a medicinal product for human use, as defined in Article 2 of Directive 65/65/EEC;

  2. (b)

    ‘orphan medicinal product’ means a medicinal product designated as such under the terms and conditions of this Regulation;

  3. (c)

    ‘sponsor’ means any legal or natural person, established in the Community, seeking to obtain or having obtained the designation of a medicinal product as an orphan medicinal product;

  4. (d)

    ‘Agency’ means the European Agency for the Evaluation of Medicinal Products.

Annotations

Textual amendments

F1

Regulation revoked in part (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(f) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)